Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
1(33%)
Results Posted
200%(2 trials)
Terminated
1(33%)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(1)
Terminated(1)

Detailed Status

Completed1
Terminated1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
50.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed133%
terminated133%
recruiting133%

Recent Activity

1 active trials
Showing 3 of 3
recruitingnot_applicable

Safety and Effectiveness Evaluation of the COLO-BT as an Alternative Treatment to the Ileostomy

NCT05826743
completednot_applicable

SafeHeal Anastomosis Feasibility Evaluation (SAFE)-2023 Study

NCT06540807
terminatednot_applicable

SafeHeal Colovac Colorectal Anastomosis Protection Device Evaluation (SAFE-2) Pivotal Study

NCT05010850

Clinical Trials (3)

Showing 3 of 3 trials
NCT05826743Not Applicable

Safety and Effectiveness Evaluation of the COLO-BT as an Alternative Treatment to the Ileostomy

Recruiting
NCT06540807Not Applicable

SafeHeal Anastomosis Feasibility Evaluation (SAFE)-2023 Study

Completed
NCT05010850Not Applicable

SafeHeal Colovac Colorectal Anastomosis Protection Device Evaluation (SAFE-2) Pivotal Study

Terminated

All 3 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
3